Evidence map›Paper›PMID 42661879›Full record

ArticleFrontiers in microbiomes2026

A generalized supervised contrastive learning framework for integrative multi-omics prediction models.

Sen Yang, Shidan Wang, Yiqing Wang, Ruichen Rong, Bo Li, Andrew Y Koh, Guanghua Xiao, Qiwei Li, Dajiang Liu, Xiaowei Zhan

Abstract read
In one paragraph

Article in Frontiers in microbiomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sen YangDepartment of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, PA, United States.
Shidan WangQuantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Yiqing WangDepartment of Statistics and Data Science, Southern Methodist University, Dallas, TX, United States.
Ruichen RongQuantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Bo LiDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Andrew Y KohHarold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Guanghua XiaoQuantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Qiwei LiDepartment of Mathematical Sciences, University of Texas at Dallas, Richardson, TX, United States.
Dajiang LiuDepartment of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, PA, United States.
Xiaowei ZhanQuantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States.

Funding

Methods to unveil sex-specific genetic architecture in trans-ancestry meta-analysisR01HG011035 · NHGRI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Bibo Jiang · 2022 to 2026
$3.8M
Antibiotic Resistance Determination Utilizing Machine LearningU01AI169298 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GREENBERG, DAVID ELIHU, ZHAN, XIAOWEI · 2022 to 2024
$1.4M
NHGRI NIH HHS R01 HG011035NIAID NIH HHS U01 AI169298
6 · The paper itself

Abstract

Advancements in multi-omics research have demonstrated the potential of integrating human microbiome and metabolomics data to better understand physiological processes and improve prediction accuracy in studies of human health. While conventional models utilizing single-omics data provide valuable perspectives, they often fail to capture the complexity of biological systems. Recent developments in supervised contrastive learning frameworks have enhanced predictive performance for categorical responses, yet limitations persist in extending these methods to continuous outcomes. A robust model capable of addressing these gaps could significantly enhance multi-omics predictions and provide new insights into complex biological interactions. Here, we present MB-SupCon-cont, a novel supervised contrastive learning framework designed for both categorical and continuous responses in multi-omics data. MB-SupCon-cont improves prediction accuracy by incorporating a generalized contrastive loss function that defines similarity and dissimilarity for continuous responses using three distance-based weighting methods. Through simulation studies and two real-world datasets for Type 2 Diabetes (T2D) and High-Fat Diet (HFD), we demonstrate that MB-SupCon-cont consistently achieves lower prediction errors than tuned conventional models, canonical correlation analysis, and autoencoder baselines, with most reaching statistical significance. We further provide a validation-based rule for selecting the weighting method and show that the learned embeddings align more closely with the response and recover known microbe and metabolite associations. The framework also provides superior representation learning and improves data visualization in lower-dimensional spaces. These findings suggest that MB-SupCon-cont is a powerful tool for general multi-omics prediction and may have broad applicability in biomedical research.

Indexed as

metabolomemicrobiomemulti-omics integrationpredictive modelingrepresentation learningsupervised contrastive learning

Identifiers

PMID42661879
PMCPMC13518532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.